1. Weatherall DJ, Clegg JB. The thalassemia syndromes. 4th ed. Oxford, England: Blackwell Science Ltd, 2001.
2. Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med. 2005;353:1135–46. Article|PubMed|ISI|ChemPort
3. Cao A, Galanello R. Beta-thalassemia. Available at:
http://www.geneclinics.org
. Accessed 1 Dec 2005.
4. Olivieri N, Weatherall DJ. Clinical aspects of β-thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, editors. Disorders of hemoglobin, genetics, pathophysiology, and clinical management. Cambridge, England: Cambridge University, 2001;277–341.
5. Voskaridou E, Anagnostopoulos A, Konstantopoulos K, et al. Zoledronic acid for the treatment of osteoporosis in patients with beta-thalassemia: results from a single-center, randomized, placebo-controlled trial. Haematologica. 2006;91:1193–202.